Pharma boss: Incentives based on outcomes will optimise EU healthcare

By |maj 7th, 2018|efficiency in healthcare, EFPIA, Healthcare and austerity, healthcare systems, News, pharmaceutical companies, SPC manufacturing waiver|

An outcomes-based approach for incentives in the pharmaceutical sector would help optimise the entire healthcare systems, Nathalie Moll told EURACTIV.com in an interview.

Komentarji so izklopljeni za Pharma boss: Incentives based on outcomes will optimise EU healthcare

Access to medicines: Let’s have better care, for more patients [Sponsored]

By |oktober 18th, 2017|ageing population, Biosimilar medicines, efficiency in healthcare, generic medicine, Healthcare and austerity, healthcare systems, News, value added medicines|

Marc-Alexander Mahl is President of Medicines for Europe. Europe’s healthcare model is under pressure. Populations are ageing in Europe – with the number of Europeans aged 65 or over set to rise by 45 million between 2015 and 2050.(1) This brings with it greater healthcare costs: currently, around 50 million EU citizens are estimated to […]

Komentarji so izklopljeni za Access to medicines: Let’s have better care, for more patients [Sponsored]